参考文献/References:
[1] Li C,Li X,Han H,et al. Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: a meta-analysis of randomized, controlled trials[J].Medicine(Baltimore),2016,95(26):e4088.DOI:10.1097/MD.0000000000004088.
[2] Bahne E,Hansen M,Brønden A,et al. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin[J].Diabetes Obes Metab,2016,18(10):955-961.DOI: 10.1111/dom.12697.
[3] Gu Y,Wang X,Li J,et al.Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment[J].Nat Commun,2017,8(1):1785. DOI:10.1038/s41467-017-01682-2.
[4] Su B,Liu H,Li J,et al.Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus[J].J Diabetes,2015,7(5):729-739.DOI:10.1111/1753-0407.12232.
[5] 王瑞风. 大黄酸改善糖尿病小鼠糖代谢的肠道机制研究[D]. 南京大学,2016.
[6] Clemente JC,Ursell LK,Parfrey LW,et al. The impact of the gut microbiota on human health: an integrative view[J].Cell,2012,148(6):1258-1270.DOI:10.1016/j.cell.2012.01.035.
[7] Singh S,Sharma RK,Malhotra S,et al.Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats[J].Benef Microbes,2017,8(2):243-255.DOI:10.3920/BM2016.0090.
[8] Kimura I,Ozawa K,Inoue D,et al.The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43[J].Nat Commun,2013,4:1829.DOI:10.1038/ncomms2852.
[9] den Besten G,Bleeker A,Gerding A,et al.Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation[J].Diabetes,2015,64(7):2398-2408.DOI:10.2337/db14-1213.
[10] Park J,Kim M,Kang SG,et al.Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway[J].Mucosal Immunol,2015,8(1):80-93.DOI:10.1038/mi.2014.44.
[11] Aw W,Fukuda S.Understanding the role of the gut ecosystem in diabetes mellitus[J].J Diabetes Investig,2018,9(1):5-12.DOI:10.1111/jdi.12673.
[12] Ma H,Patti ME.Bile acids,obesity,and the metabolic syndrome[J].Best Pract Res Clin Gastroenterol,2014,28(4):573-583.DOI:10.1016/j.bpg.2014.07.004.
[13] Sayin SI,Wahlström A,Felin J,et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist[J].Cell Metab,2013,17(2):225-235.DOI:10.1016/j.cmet.2013.01.003.
[14] Stepanov V,Stankov K,Mikov M.The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders[J].J Recept Signal Transduct Res,2013,33(4):213-223.DOI:10.3109/10799893.2013.802805.
[15] Boutagy NE,McMillan RP,Frisard MI,et al.Metabolic endotoxemia with obesity: is it real and is it relevant?[J].Biochimie,2016,124:11-20.DOI:10.1016/j.biochi.2015.06.020.
[16] 冯燕海,黄亚兰,王裴,等.短链脂肪酸对内毒素/脂多糖引起的人肠上皮细胞屏障功能损害的作用及相关机制[J].中华烧伤杂志,2018,34(4):214-218.DOI:10.3760/cma.j.issn.1009-2587.2018.04.005.
[17] Chakraborti CK.New-found link between microbiota and obesity[J].World J Gastrointest Pathophysiol,2015,6(4):110-119.DOI:10.4291/wjgp.v6.i4.110.
[18] Napolitano A,Miller S,Nicholls AW,et al.Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus[J].PLoS One,2014,9(7):e100778. DOI:10.1371/journal.pone.0100778.
[19] McCarty MF,DiNicolantonio JJ.Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1[J].Open Heart,2015,2(1):e000205.DOI:10.1136/openhrt-2014-000205.
[20] Gu Y,Wang X,Li J,et al.Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment[J].Nat Commun,2017,8(1):1785. DOI:10.1038/s41467-017-01682-2.
[21] Liu D, Zhang Y, Liu Y,et al. Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway[J].Exp Clin Endocrinol Diabetes,2018,[Epub ahead of print].DOI:10.1055/s-0043-125066.
[22] 李燕,陈素红,吉星,等. 白术多糖对自发性2型糖尿病小鼠血糖及相关指标的影响[J]. 中国实验方剂学杂志,2015,21(10):162-165.DOI:10.13422/j.cnki.syfjx.2015100162.
[23] Zhang Y,Tang K,Deng Y,et al.Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats[J].Biomed Pharmacother,2018,102:1025-1036. DOI:10.1016/j.biopha.2018.03.158.
相似文献/References:
[1]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[2]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(05):270.
[3]顾子良 王洪东 朱大龙 毕艳.2型糖尿病治疗方法对肠道菌群的影响[J].国际内分泌代谢杂志,2018,38(04):254.[doi:10.3760/cma.j.issn.1673-4157.2018.04.009]
Gu Ziliang,Wang Hongdong,Zhu Dalong,et al.Effects of treatment of type 2 diabetes on gut microbiota[J].International Journal of Endocrinology and Metabolism,2018,38(05):254.[doi:10.3760/cma.j.issn.1673-4157.2018.04.009]
[4]夏心怡 张洪梅.肠道菌群及其代谢产物调节糖脂代谢的机制[J].国际内分泌代谢杂志,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
Xia Xinyi,Zhang Hongmei.Regulating mechanism of glycolipid metabolism by intestinal microbiota and its metabolites[J].International Journal of Endocrinology and Metabolism,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
[5]周晓聪 张晓黎.益生菌与妊娠糖尿病的相关性[J].国际内分泌代谢杂志,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
Zhou Xiaocong,Zhang Xiaoli.Relationship between probiotics and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
[6]万仕炜 郁梅 方彭华 张真稳.小檗碱改善胰岛素抵抗的相关机制[J].国际内分泌代谢杂志,2018,38(05):333.[doi:10.3760/cma.j.issn.1673-4157.2018.05.012]
Wan Shiwei*,Yu Mei,Fang Penghua,et al.Related mechanism of berberine in improving insulin resistance[J].International Journal of Endocrinology and Metabolism,2018,38(05):333.[doi:10.3760/cma.j.issn.1673-4157.2018.05.012]
[7]张晓蕾 敖娜 都健.维生素D以肠道菌群为靶点治疗非酒精性脂肪性肝病的
研究进展[J].国际内分泌代谢杂志,2019,39(05):311.[doi:10.3760/cma.j.issn.1673-4157.2019.05.006]
Zhang Xiaolei,Ao Na,Du Jian.Advances in the treatment of non-alcoholic fatty liver disease with vitamin D targeting intestinal flora[J].International Journal of Endocrinology and Metabolism,2019,39(05):311.[doi:10.3760/cma.j.issn.1673-4157.2019.05.006]
[8]叶凌霞 洪洁.多囊卵巢综合征与肠道菌群[J].国际内分泌代谢杂志,2019,39(05):345.[doi:10.3760/cma.j.issn.1673-4157.2019.05.014]
Ye Lingxia,Hong Jie.Polycystic ovary syndrome and gut microbiota[J].International Journal of Endocrinology and Metabolism,2019,39(05):345.[doi:10.3760/cma.j.issn.1673-4157.2019.05.014]
[9]陈莹 刘子荣.减重手术改善代谢的新机制[J].国际内分泌代谢杂志,2020,40(04):275.[doi:10.3760/cma.j.issn.1673-4157.2020.04.014]
Chen Ying,Liu Zirong.The novel mechanisms of weight-loss surgery in improving metabolism[J].International Journal of Endocrinology and Metabolism,2020,40(05):275.[doi:10.3760/cma.j.issn.1673-4157.2020.04.014]
[10]詹永颖,黄汉伟.益生菌对妊娠期糖尿病的影响及相关机制[J].国际内分泌代谢杂志,2021,41(02):124.[doi:10.3760/cma.j.cn121383-20200821-08037]
Zhan Yongying,Huang Hanwei..Effects and mechanism of probiotics on gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2021,41(05):124.[doi:10.3760/cma.j.cn121383-20200821-08037]
[11]韦晓,张少红,孙烁烁,等.肠道菌群：口服降糖药物有效性和安全性的重要靶点[J].国际内分泌代谢杂志,2023,43(01):14.[doi:10.3760/cma.j.cn121383-20210915-09040]
Wei Xiao,Zhang Shaohong,Sun Shuoshuo,et al.Gut microbiota: the important target of efficiency and safety of oral hypoglycemic agents[J].International Journal of Endocrinology and Metabolism,2023,43(05):14.[doi:10.3760/cma.j.cn121383-20210915-09040]